Supergut Officially Launches Nationwide at Target Stores

Supergut, a prominent player in the gut-health market, has announced a significant retail expansion with its nationwide launch in Target stores.

Supergut Officially Launches Nationwide at Target Stores

Supergut, a prominent player in the gut-health market, has announced a significant retail expansion with its nationwide launch in Target stores. This strategic move aims to bring Supergut's innovative GLP-1 superfoods closer to consumers, capitalizing on the fact that over 75% of the U.S. population resides within 10 miles of a Target store. Over the past year, Supergut more than tripled its sales due to its timely, triple-duty solution for the gut health and Ozempic® symptoms.

The collaboration with Target marks a crucial step for Supergut, which now offers a comprehensive selection of its prebiotic superfood products, including nutrient-rich shakes and innovative GLP-1 Booster powders. Priced at an accessible $29.99, these products respond to the growing consumer interest in gut and digestive health alternatives.

Supergut: A natural alternative to weight loss

  • It’s the natural alternative for those looking to curb cravings and boost GLP-1 through nutrition rather than medication.
  • It’s the gut healthy solution for people looking to improve digestive health and those dealing with the weight loss drugs’ notorious GI side effects, such as constipation and nausea.
  • It’s the sustainable off-ramp for people tapering down or ending the use of GLP-1 medication who aim to maintain results over the long term.

“I founded Supergut in my late sister’s memory, who suffered from metabolic diseases, to empower everybody with any body to take control of their health,” said Supergut, Founder and CEO Marc Washington. “Over 75% of the U.S. population lives within 10 miles of a Target store, so partnering with Target is key to our mission by making it much easier for the masses to learn about and enjoy our delicious, gut-healthy superfoods.”

Scientifically Proven Results

The brand's products are backed by research and have undergone extensive clinical validation — a rarity among dietary supplements. In 2023, Supergut became the first – and remains the only – gut health nutrition brand clinically-validated in a gold-standard, placebo-controlled study. The peer-reviewed findings, published in the highly respected journal Diabetes, Obesity and Metabolism, demonstrated that consuming Supergut daily can significantly improve weight management, blood sugar control, digestion, and other health-related quality-of-life measures, including energy, immunity, and sleep.

In fact, based on an April 2024 survey of over 1,300 Supergut customers, 78% of GLP-1 users who purchased Supergut to help maintain or improve results found it to be effective at curbing cravings and supporting weight management. This scientific foundation boosts Supergut's credibility, particularly as more consumers pivot from pharmaceutical solutions like Ozempic® to natural alternatives for managing weight and cravings.

Those who consumed Supergut while on a GLP-1 drug were 4x less likely to experience severe, GI-related side effects, with 56% experiencing minimal to none at all. As the brand reaches more Americans, it stands poised not only to boost digestive health but also to inspire a shift towards sustainable, science-backed wellness choices.